Use of infliximab to treat psoriatic arthritis in HIV-positive patients

Joint Bone Spine

Volumn 74, Issue 2, 2007, Pages 197-200

  Sellam, Jérémie ^a   Bouvard, Béatrice ^b   Masson, Charles ^b   Rousière, Mickael ^a   Villoutreix, Caroline ^a   Lacombe, Karine ^a   Khanine, Vanessa ^a   Chennebault, Jean Marie ^b   Leclech, Christian ^b   Audran, Maurice ^b   Berenbaum, Francis ^a  

^a HÔPITAL SAINT ANTOINE   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

AIDS; HIV; Infliximab; Methotrexate; Psoriatic arthritis; TNF alpha antagonists

Indexed keywords

ABACAVIR; ACICLOVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; BENZATHINE CLOXACILLIN; COTRIMOXAZOLE; CYCLINE; DIDANOSINE; EFAVIRENZ; ENFUVIRTIDE; FLUCONAZOLE; INFLIXIMAB; LAMIVUDINE; METHOTREXATE; METHYLPREDNISOLONE; MORPHINE SULFATE; PENTAMIDINE; PREDNISONE; RITONAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE;

ADD ON THERAPY; ADULT; ANAMNESIS; ARTHRITIS; ARTHROPATHY; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG TOLERANCE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MALE; MULTIPLE CYCLE TREATMENT; NEUROPATHY; PANCYTOPENIA; PATIENT COMPLIANCE; PSORIATIC ARTHRITIS; SEROLOGY; SYNOVITIS; SYPHILIS; URETHRITIS; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MALE; TREATMENT OUTCOME;

EID: 34247117842     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2006.05.012     Document Type: Article

References (17)

1. Cuellar M.L., and Espinoza L.R. Rheumatic manifestations of HIV-AIDS. Baillieres Best Pract Res Clin Rheumatol 14 (2000) 579-593
2. Masson C., Chennebault J.M., and Leclech C. Is HIV infection contraindication to the use of methotrexate in psoriatic arthritis?. J Rheumatol 22 (1995) 2191
3. www.cri-net.com; March 2006.
4. Cepeda E.J., Williams F.M., Ishimori M., Weisman M.H., and Reveille J.D. The use of anti-TNF therapy in HIV positive individuals with rheumatic disease. Arthritis Rheum 9 Suppl (2005) S249
5. Aboulafia D.M., Bundow D., Wilske K., and Ochs U.I. Etanercept for the treatment of human immunodeficiency virus-associated psoriatic arthritis. Mayo Clin Proc 75 (2000) 1093-1098
6. Gaylis N. Infliximab in the treatment of an HIV-positive patient with Reiter's syndrome. J Rheumatol 30 (2003) 407-411
7. Bartke U., Venten I., Kreuter A., Gubbay S., Altmeyer P., and Brockmeyer N.H. Human immunodeficiency virus-associated psoriasis and psoriatic arthritis treated with infliximab. Br J Dermatol 150 (2004) 784-786
8. Tourne L., Durez P., Van Vooren J.P., Farber C.M., Liesnard C., and Heenen M. Alleviation of HIV-associated psoriasis and psoriatic arthritis with cyclosporine. J Am Acad Dermatol 37 (1997) 501-502
9. Winchester R., Bernstein D.H., Fischer H.D., Enlow R., and Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med 106 (1987) 19-26
10. Duh E.J., Maury W.J., Folks T.M., Fauci A.S., and Rabson A.B. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A 86 (1989) 5974-5978
11. Dezube B.J., Lederman M.M., Chapman B., Georges D.L., Dogon A.L., Mudido P., et al. The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levels. J Infect Dis 176 (1997) 807-810
12. Valdez H., and Lederman M.M. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev (1997) 187-228
13. Calabrese L.H., Zein N., and Vassilopoulos D. Safety of antitumour necrosis factor (anti-TNF) therapy in patients with chronic viral infections: hepatitis C, hepatitis B, and HIV infection. Ann Rheum Dis 63 Suppl (2004) ii18-ii24
14. Sha B.E., Valdez H., Gelman R.S., Landay A.L., Agosti J., Mitsuyasu R., et al. Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2. AIDS Res Hum Retroviruses 18 (2002) 661-665
15. Wallis R.S., Kyambadde P., Johnson J.L., Horter L., Kittle R., Pohle M., et al. A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. Aids 18 (2004) 257-264
16. Walker R.E., Spooner K.M., Kelly G., McCloskey R.V., Woody J.N., Falloon J., et al. Inhibition of immunoreactive tumor necrosis factor-alpha by a chimeric antibody in patients infected with human immunodeficiency virus type 1. J Infect Dis 174 (1996) 63-68
17. Wachi K., Prasertsuntarasai T., Kishimoto M., and Uramoto K. T-cell lymphopenia associated with infliximab and cyclophosphamide. Am J Med Sci 330 (2005) 48-51